Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

352 ARTÍCULOS , VIENDO DEL 196 AL 210

Imaging markers of neuroinflammation in aging and Alzheimer's disease and related dementia: A comprehensive review

Chaudhary S, Chao HH, Agarwal K, Gupta S, Li CR.

Neurosci Biobehav Rev. 2025 Sep;176:106270. doi: 10.1016/j.neubiorev.2025.106270. Epub 2025 Jun 25.

Diabetes affects AD through plasma Aβ40: A Mendelian randomization study

Yang Q, Huang D, Zhang Z, Gao H, Wu J, Zhong H, Guo X, Wang Y, Zhou H, Liu C, Duan X.

Neuroscience. 2025 May 24;575:131-139. doi: 10.1016/j.neuroscience.2025.04.025. Epub 2025 Apr 13.

New Research on Biomarkers in Alzheimer's Continuum

Vecchio I, Colica C.

Rev Recent Clin Trials. 2025;20(3):211-231. doi: 10.2174/0115748871331138250114052615.

Alzheimer's disease: assessing the therapeutic potential of anti-Aβ (Beta-Amyloid) treatments

Almutairi JA.

Cell Mol Biol (Noisy-le-grand). 2025 Feb 2;71(1):111-117. doi: 10.14715/cmb/2025.70.1.12.

Unlocking ocular biomarkers for early detection of Alzheimer's disease

Dave N, Lee M, Pavlou H, Im O, Goh K, Ulin S, Malzbender K, Shobin E, Sukumar A.

Alzheimers Dement. 2025 Feb;21(2):e14567. doi: 10.1002/alz.14567. Epub 2025 Feb 19.

The Interplay Between Exosomes and Gut Microbiota in Neuroinflammation: A New Frontier in Alzheimer's Disease

Uceda S, Reiriz M, Echeverry-Alzate V, Beltrán-Velasco AI.

Int J Mol Sci. 2025 Jun 18;26(12):5828. doi: 10.3390/ijms26125828.

Exploring the Role of microRNAs as Blood Biomarkers in Alzheimer's Disease and Frontotemporal Dementia

Petracci I, Bellini S, Goljanek-Whysall K, Quinlan LR, Fiszer A, Cakmak A, Njume CM, Borroni B, Ghidoni R.

Int J Mol Sci. 2025 Apr 5;26(7):3399. doi: 10.3390/ijms26073399.

Plasma pTau217 ratio predicts continuous regional brain tau accumulation in amyloid-positive early Alzheimer's disease

Devanarayan V, Charil A, Horie K, Doherty T, Llano DA, Andreozzi E, Sachdev P, Ye Y, Murali LK, Zhou J, Reyderman L, Hampel H, Kramer LD, Dhadda S, Irizarry MC; Alzheimer's Disease Neuroimaging Initiative (ADNI).

Alzheimers Dement. 2025 Feb;21(2):e14411. doi: 10.1002/alz.14411. Epub 2024 Nov 22.

The Role of Blood-Based Biomarkers in Transforming Alzheimer's Disease Research and Clinical Management: A Review

Pacoova Dal Maschio V, Roveta F, Bonino L, Boschi S, Rainero I, Rubino E.

Int J Mol Sci. 2025 Sep 3;26(17):8564. doi: 10.3390/ijms26178564.

Differences in Alzheimer's disease blood biomarker stability: Implications for the use of tau/amyloid ratios

Figdore DJ, Schuder BJ, Ashrafzadeh-Kian S, Gronquist T, Bornhorst JA, Algeciras-Schimnich A.

Alzheimers Dement. 2025 Apr;21(4):e70173. doi: 10.1002/alz.70173.

Comparison of plasma ALZpath p-Tau217 with Lilly p-Tau217 and p-Tau181 in a neuropathological cohort

Bali D, Salvadó G, Beach TG, Serrano GE, Atri A, Reiman EM, Jeromin A, Hansson O, Janelidze S.

Acta Neuropathol Commun. 2025 Jun 30;13(1):144. doi: 10.1186/s40478-025-02064-2.

Transthyretin as a therapeutic target: the future of disease-modifying therapies for Alzheimer's disease

Shaw S, Porel P, Aran KR.

Mol Biol Rep. 2025 Apr 8;52(1):370. doi: 10.1007/s11033-025-10485-4.

Beyond binary classification: Comparing three region-based multi-phase Aβ staging systems

Cui L, Zhang Z, Huang CC, Yuan CY, Tu YY, Wang M, Guan YH, Li YH, Xie F, Guo QH.

Alzheimers Dement. 2025 May;21(5):e70253. doi: 10.1002/alz.70253.

Atypical Alzheimer's dementia: Addressing the subtypes, epidemiology, atypical presentations, diagnostic biomarkers, and treatment updates

Vora N, Patel P, Marsool MDM, Marsool ADM, Sunasra R, Ladani P, Pati S, Khoont D, Prajjwal P, Ranjan R.

Dis Mon. 2025 May;71(5):101863. doi: 10.1016/j.disamonth.2025.101863. Epub 2025 Feb 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias